These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2911870

  • 1. Risk factors for sensitization by blood transfusions. Comparison of the UW/Madison and UC/San Francisco donor-specific transfusion experience.
    Burlingham WJ, Stratta R, Mason B, Lorentzen D, Feyzi J, Sollinger HW, Belzer FO.
    Transplantation; 1989 Jan; 47(1):140-4. PubMed ID: 2911870
    [Abstract] [Full Text] [Related]

  • 2. Multivariate analysis of risk factors for sensitization and early rejection episodes in a donor-specific transfusion plus azathioprine protocol.
    Burlingham WJ, Stratta RJ, Mason B, Ambrust MJ, Kalayoglu M, Belzer FO, Sollinger HW.
    Transplantation; 1988 Feb; 45(2):342-5. PubMed ID: 3257833
    [Abstract] [Full Text] [Related]

  • 3. Two patterns of sensitization demonstrated by recipients of donor-specific transfusion. Limitations to control by Imuran.
    Colombe BW, Lou CD, Salvatierra O, Garovoy MR.
    Transplantation; 1987 Oct; 44(4):509-15. PubMed ID: 3313837
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
    Flye MW, Burton K, Mohanakumar T, Brennan D, Keller C, Goss JA, Sicard GA, Anderson CB.
    Transplantation; 1995 Dec 27; 60(12):1395-401. PubMed ID: 8545863
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Incidental and purposeful random donor blood transfusion. Sensitization and transplantation.
    Pfaff WW, Howard RJ, Scornik JC, Day C, Renderer J, Scott J, Fennel RS, Peterson JC, Salomon DR, Patton PR.
    Transplantation; 1989 Jan 27; 47(1):130-3. PubMed ID: 2643223
    [Abstract] [Full Text] [Related]

  • 9. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens.
    Leivestad T, Albrechtsen D, Flatmark A, Thorsby E.
    Transplantation; 1986 Jul 27; 42(1):35-8. PubMed ID: 3523880
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.
    Lagaaij EL, Hennemann IP, Ruigrok M, de Haan MW, Persijn GG, Termijtelen A, Hendricks GF, Weimar W, Claas FH, van Rood JJ.
    N Engl J Med; 1989 Sep 14; 321(11):701-5. PubMed ID: 2671729
    [Abstract] [Full Text] [Related]

  • 12. Renal transplantation: cyclosporin A and antibody development after donor-specific transfusion.
    al-Muzairai IA, Innes A, Hillis A, Stewart KN, Bone JM, Catto GR, Macleod AM.
    Kidney Int; 1989 Apr 14; 35(4):1057-63. PubMed ID: 2651767
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E, Castro-Panete MJ, Castillo-Rama M, Morales P, Lora-Pablos D, Valero-Hervás D, Ruiz-García R, Apaza J, Talayero P, Andrés A, Morales JM, Paz-Artal E.
    Transplantation; 2013 Jul 15; 96(1):70-8. PubMed ID: 23624543
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.
    Aalten J, Bemelman FJ, van den Berg-Loonen EM, Claas FH, Christiaans MH, de Fijter JW, Hepkema BG, Hené RJ, van der Heide JJ, van Hooff JP, Lardy NM, Lems SP, Otten HG, Weimar W, Allebes WA, Hoitsma AJ.
    Nephrol Dial Transplant; 2009 Aug 15; 24(8):2559-66. PubMed ID: 19474284
    [Abstract] [Full Text] [Related]

  • 17. Factors affecting kidney-transplant outcome in recipients with lupus nephritis.
    Tang H, Chelamcharla M, Baird BC, Shihab FS, Koford JK, Goldfarb-Rumyantzev AS.
    Clin Transplant; 2008 Aug 15; 22(3):263-72. PubMed ID: 18482047
    [Abstract] [Full Text] [Related]

  • 18. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH, van Buren CT, Lewis RM, Frazier OH, Cooley D, Kahan BD.
    Transplantation; 1988 Feb 15; 45(2):333-7. PubMed ID: 3278425
    [Abstract] [Full Text] [Related]

  • 19. Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.
    Akgul SU, Ciftci HS, Temurhan S, Caliskan Y, Bayraktar A, Tefik T, Kaya IA, Canitez IO, Demir E, Yazici H, Bakkaloglu H, Aydin AE, Turkmen A, Nane I, Aydin F, Oguz FS.
    Transplant Proc; 2017 Apr 15; 49(3):425-429. PubMed ID: 28340805
    [Abstract] [Full Text] [Related]

  • 20. Factors influencing HLA sensitization in implantable LVAD recipients.
    Massad MG, Cook DJ, Schmitt SK, Smedira NG, McCarthy JF, Vargo RL, McCarthy PM.
    Ann Thorac Surg; 1997 Oct 15; 64(4):1120-5. PubMed ID: 9354538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.